over 4 years ago // Sponsored by Gilead

What should a new era of progress in global health look like and how can it be ushered in? Gilead's Harald Nusser shares some takeaways from a recent event on the topic.

over 7 years ago // Produced in Partnership: Taking the Pulse

Most companies want their corporate responsibility programs to work, but few develop the evidence base to understand whether they actually do. Experts weigh in on how to achieve social change at scale.

almost 8 years ago // Sponsored by Novartis

A new independent policy study, commissioned by Novartis, reveals controversial views about what African experts think is the best way to push forward progress on malaria eliminations. This guest column details the biggest findings of the Malaria Futures for Africa, or MalaFA study, and explains why we need to take advantage of these African insights and learnings.

over 9 years ago // Access To Medicines

Health systems in lower-income countries must now cope with the new epidemic of chronic diseases without losing focus of the ongoing fight against infectious diseases, asserts Harald Nusser, global head at Novartis Access, in this #Access2Meds guest column.